Accessibility settings

Published on in Vol 12 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/68101, first published .
Patient in hospital bed with headscarf smiles at visitor reading a book.

Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study

Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study

Journals

  1. Halpin S. Financial toxicity as logistical and relational burden across the lifespan during autologous transplant preparation. Frontiers in Cancer Control and Society 2026;4 View
  2. Amaeshi L, Imeh M, Ossai J. Sociodemographic Disparities in Access to Allogeneic Stem Cell Transplantation Among Patients Hospitalized With Relapsed Acute Myeloid Leukemia. Cureus 2026 View